Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome
Evaluation of Corticosteroid as Modulators of Humeral and Cellular Immune Response in Open Heart Surgery in Egyptian Population
Sponsor: Assiut University
Listed as NCT03876041, this PHASE4 trial focuses on Systemic Inflammatory Response Syndrome and remains completed. Sponsored by Assiut University, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Not Yet Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE4
▶ Show 1 earlier version
-
Apr 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assiut University
For direct contact, visit the study record on ClinicalTrials.gov .